Vanguard Investments Australia’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Buy
13,241
+2,376
+22% +$51.7K ﹤0.01% 1792
2026
Q1
$189K Buy
+10,865
New +$206K ﹤0.01% 2062

Other funds holding CDNA

Vanguard Investments Australia's CDNA Position: Q2 2026 in Review

Vanguard Investments Australia increased its CareDx (CDNA) stake by 22% in Q2 2026, buying an estimated $51.7K and bringing the position to 13,241 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Vanguard Investments Australia first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Vanguard Investments Australia held 13,241 shares of CareDx worth $377K as of Q2 2026.
  • Vanguard Investments Australia bought 2,376 CareDx shares in Q2 2026, an estimated $51.7K.
  • CareDx made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1792 holding.
  • Vanguard Investments Australia first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.